Ever Supreme Bio Technology Co., Ltd.(TW:6712)
NT$148.00-0.50 (-0.34%)
TW:6712
Ever Supreme Bio Technology Co., Ltd. financials statements
NT$148.00
At close:-0.50 (-0.34%)
Ever Supreme Bio Technology Co., Ltd. (6712) Income Statement
Ever Supreme Bio Technology Co., Ltd. Income Statement
Last quarter (Q2 2026), Ever Supreme Bio Technology Co., Ltd.'s total revenue was NT$272.06M, an increase of 23.11% from the same quarter last year. In Q2, Ever Supreme Bio Technology Co., Ltd.'s net income was NT$90.05M. See Ever Supreme Bio Technology Co., Ltd.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| NT$ 1.02B | NT$ 933.81M | NT$ 758.39M | NT$ 627.51M | NT$ 438.84M | |
| NT$ 721.33M | NT$ 660.04M | NT$ 484.75M | NT$ 414.56M | NT$ 245.48M | |
| NT$ 282.33M | NT$ 194.40M | NT$ 147.02M | NT$ 130.76M | NT$ 129.28M | |
| Depreciation and Amortization | NT$ 23.18M | NT$ 30.89M | NT$ 32.31M | NT$ 35.55M | NT$ 35.82M |
| NT$ 462.17M | NT$ 491.76M | NT$ 655.52M | NT$ 300.16M | NT$ 433.26M | |
| NT$ 439.00M | NT$ 421.19M | NT$ 337.73M | NT$ 264.61M | NT$ 397.44M | |
| NT$ 85.34M | NT$ 39.55M | NT$ 285.28M | NT$ -19.69M | NT$ 280.62M | |
| NT$ 524.33M | NT$ 460.74M | NT$ 623.01M | NT$ 264.10M | NT$ 396.82M | |
| NT$ 429.43M | NT$ 367.25M | NT$ 539.40M | NT$ 200.71M | NT$ 369.60M | |
| Per Share Metrics | |||||
| Basic EPS | NT$ 4.88 | NT$ 4.14 | NT$ 6.58 | NT$ 2.68 | NT$ 4.96 |
| Diluted EPS | NT$ 4.88 | NT$ 4.14 | NT$ 6.56 | NT$ 2.66 | NT$ 4.91 |
| Weighted Average Shares Outstanding | 88.00M | 80.67M | 81.92M | 74.91M | 74.57M |
| Weighted Average Shares Outstanding (Diluted) | 88.00M | 80.72M | 82.22M | 75.38M | 75.27M |
Currency in TWD
